Unknown

Dataset Information

0

[DFCI-CPDM] [PDX] [NIBRX-2357] Biliary Tract Carcinoma

ABSTRACT:

SUBMITTER:  

PROVIDER: S-CMO9093 | biostudies-other |

REPOSITORIES: biostudies-other

Json Xml

Similar Datasets

Unknown [DFCI-CPDM] [PDX] [NIBRX-5143] Biliary Tract Carcinoma
| S-CMO9082 | biostudies-other
Unknown Systemic treatment options for advanced biliary tract carcinoma.
| S-EPMC7519922 | biostudies-literature
Unknown Molecular genetics and targeted therapeutics in biliary tract carcinoma.
| S-EPMC4721969 | biostudies-literature
Unknown Mutational spectrum and precision oncology for biliary tract carcinoma.
| S-EPMC7978308 | biostudies-literature
Unknown The case for immune-based approaches in biliary tract carcinoma.
| S-EPMC5074847 | biostudies-literature
Unknown Immunotherapeutic approaches in biliary tract carcinoma: Current status and emerging strategies.
| S-EPMC4644856 | biostudies-literature
Unknown Lenvatinib Beyond First-Line Therapy in Patients With Advanced Biliary Tract Carcinoma.
| S-EPMC8928459 | biostudies-literature
Unknown Establishment and drug screening of patient-derived extrahepatic biliary tract carcinoma organoids.
| S-EPMC8487492 | biostudies-literature
Genomics Differences in the biliary microbiome between biliary tract cancer and benign biliary disease
2025-08-30 | E-MTAB-15494 | biostudies-arrayexpress
Unknown Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma.
| S-EPMC7216452 | biostudies-literature